These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30476369)

  • 1. Tardive Oculogyric Crisis With Low-Dose Antipsychotic in an Adolescent: A Case Report.
    Gnanavel S
    Prim Care Companion CNS Disord; 2018 Nov; 20(6):. PubMed ID: 30476369
    [No Abstract]   [Full Text] [Related]  

  • 2. Not just another antipsychotic-for-conduct-problems trial.
    Blader JC
    J Am Acad Child Adolesc Psychiatry; 2014 Jan; 53(1):17-20. PubMed ID: 24342382
    [No Abstract]   [Full Text] [Related]  

  • 3. Extrapyramidal Symptoms as a Result of Risperidone Discontinuation During Combination Therapy with Methylphenidate in a Pediatric Patient.
    Pérez CA; Garcia SS; Yu RD
    J Child Adolesc Psychopharmacol; 2016 Mar; 26(2):182. PubMed ID: 26871198
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute dyskinesia on starting methylphenidate after risperidone withdrawal.
    Hollis CP; Thompson A
    Pediatr Neurol; 2007 Oct; 37(4):287-8. PubMed ID: 17903675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of metilpheniydate, risperidone and combination therapy on ECG in children with attention-deficit hyperactivity disorder.
    Karpuz D; Hallioglu O; Toros F; Tasdelen B
    J Electrocardiol; 2017; 50(4):410-415. PubMed ID: 28274540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A washout period needed before switching from a neuroleptic to an amphetamine.
    Prescrire Int; 2009 Aug; 18(102):165. PubMed ID: 19743579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TD from risperidone?
    Edleman RJ
    J Am Acad Child Adolesc Psychiatry; 1997 Jul; 36(7):867. PubMed ID: 9204659
    [No Abstract]   [Full Text] [Related]  

  • 8. Quetiapine addition in methylphenidate treatment-resistant adolescents with comorbid ADHD, conduct/oppositional-defiant disorder, and aggression: a prospective, open-label study.
    Kronenberger WG; Giauque AL; Lafata DE; Bohnstedt BN; Maxey LE; Dunn DW
    J Child Adolesc Psychopharmacol; 2007 Jun; 17(3):334-47. PubMed ID: 17630867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case of risperidone-induced tardive parkinsonism.
    Bolu A; Garip B; Öznur T; Uzun Ö
    Psychiatry Clin Neurosci; 2019 May; 73(5):285-286. PubMed ID: 30854755
    [No Abstract]   [Full Text] [Related]  

  • 10. Risperidone Added to Psychostimulant in Children with Severe Aggression and Attention-Deficit/Hyperactivity Disorder: Lack of Effect on Attention and Short-Term Memory.
    Farmer CA; Epstein JN; Findling RL; Gadow KD; Arnold LE; Kipp H; Kolko DJ; Butter E; Schneider J; Bukstein OG; McNamara NK; Molina BS; Aman MG
    J Child Adolesc Psychopharmacol; 2017 Mar; 27(2):117-124. PubMed ID: 27348211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulant-atypical antipsychotic interaction and acute dystonia.
    Benjamin E; Salek S
    J Am Acad Child Adolesc Psychiatry; 2005 Jun; 44(6):510-2. PubMed ID: 15908830
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute dystonic reaction in an adolescent on risperidone when a concomitant stimulant medication is discontinued.
    Keshen A; Carandang C
    J Child Adolesc Psychopharmacol; 2007 Dec; 17(6):867-70. PubMed ID: 18315457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylphenidate-risperidone combination in child psychiatry: A retrospective analysis of 44 cases.
    Javelot H; Glay-Ribau C; Ligier F; Weiner L; Didelot N; Messaoudi M; Socha M; Body-Lawson F; Kabuth B
    Ann Pharm Fr; 2014 May; 72(3):164-77. PubMed ID: 24780832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oculogyric crisis as an isolated extrapyramidal symptom of auto-intoxication with risperidone].
    van Renterghem L; Titeca K; Crunelle CL; Geerts P; Matthys F
    Tijdschr Psychiatr; 2019; 61(9):649-653. PubMed ID: 31560785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risperidone and tardive dyskinesia.
    Feeney DJ; Klykylo W
    J Am Acad Child Adolesc Psychiatry; 1996 Nov; 35(11):1421-2. PubMed ID: 8936904
    [No Abstract]   [Full Text] [Related]  

  • 16. Tardive oculogyric crisis associated with amisulpride monotherapy.
    Mendhekar DN; Lohia D; Kataria P
    J Postgrad Med; 2010; 56(4):305-6. PubMed ID: 20935407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing ADHD and disruptive behaviour disorders with combination psychostimulant and antipsychotic treatment.
    Elbe D; Barr AM; Honer WG; Procyshyn RM
    J Psychiatry Neurosci; 2014 May; 39(3):E32-3. PubMed ID: 24758945
    [No Abstract]   [Full Text] [Related]  

  • 18. Oculogyric crisis with exacerbation of psychosis: Possible mechanism and clinical implications.
    Thomas N; Sankar SS; Braganza D; Jayakrishnan S
    Neurosci Lett; 2009 Feb; 451(1):50-1. PubMed ID: 19121367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced extrapyramidal reactions.
    Teoh L; Allen H; Kowalenko N
    J Paediatr Child Health; 2002 Feb; 38(1):95-7. PubMed ID: 11869410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADHD Masquerading as Cautopyreiophagia Exacerbated by Risperidone and Improved With Methylphenidate in a Preschooler.
    Naguy A
    Prim Care Companion CNS Disord; 2021 Jul; 23(4):. PubMed ID: 34228405
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.